Patents by Inventor Luke A. Gilbert

Luke A. Gilbert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260109972
    Abstract: Provided are methods for determining that a candidate polypeptide in a library of polypeptides has editing activity comprising expressing in a plurality of cells: a library of first expression cassettes each comprising a nucleic acid encoding a polypeptide wherein each polypeptide in the library comprises, a first editing domain, a first linker, a nuclease-deficient RNA guided endonuclease domain, a second linker, and a second editing domain; and a second expression cassette comprising a nucleic acid encoding a guide RNA directed to a target of interest, wherein said first and second expression cassettes are expressed in the plurality of cells; separating the plurality of cells based on the expression level of the target of interest; extracting genomic DNA (gDNA) from the plurality of cells; and sequencing the gDNA of cells that have a high level expression or a low level of expression of the target of interest.
    Type: Application
    Filed: November 9, 2023
    Publication date: April 23, 2026
    Inventors: Luke A. Gilbert, Greg Pommier, Jonathan Weissman, Caroline Wilson
  • Publication number: 20260014143
    Abstract: Provided are compounds for inhibiting prostaglandin E synthase 3 (PTGES3) along with methods of treating prostate cancer by administering such compounds to a subject. The PTGES3 inhibitors has a moiety that can form a covalent bond with a thiol group, for example, of a cysteine residue of PTGES3. By forming such a bond, the inhibitor can block a site on PTGES3 that is involved with the interaction between PTGES3 and androgen receptor (AR). Since the progression of prostate cancer can depend on AR activity, blocking the interaction of PTGES3 and AR can be used to treat prostate cancer.
    Type: Application
    Filed: July 19, 2023
    Publication date: January 15, 2026
    Inventors: James E. Melnyk, Luke A. Gilbert, Kevan M. Shokat, Felix Y. Feng, Haolong Li
  • Publication number: 20230042624
    Abstract: Methods, compositions, and kits are provided for CRISPR/Cas mediated transcriptional modulation.
    Type: Application
    Filed: January 24, 2022
    Publication date: February 9, 2023
    Inventors: Luke A. Gilbert, Max Horlbeck, Martin Kampmann, Lei S. Qi, Jonathan S. Weissman
  • Patent number: 10815479
    Abstract: Provided herein are methods directed to multiplexed detection of the modulation of transcriptional activity using perturbation elements.
    Type: Grant
    Filed: June 7, 2016
    Date of Patent: October 27, 2020
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Onn Brandman, Jonathan Weissman, Calvin H. Jan, Luke A. Gilbert
  • Publication number: 20160362684
    Abstract: Provided herein are methods directed to multiplexed detection of the modulation of transcriptional activity using perturbation elements.
    Type: Application
    Filed: June 7, 2016
    Publication date: December 15, 2016
    Applicant: The Regents of the University of California
    Inventors: Onn Brandman, Jonathan Weissman, Calvin H. Jan, Luke A. Gilbert